.

Seattle Genetics reported $3.63B in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 612.77M 11.48M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
Amgen AMGN:US $ 59294M 98M
Astellas Pharma 4503:JP Y 2481843M 149448M
Bayer BAYN:GR € 128794M 3012M
Biogen BIIB:US $ 25081.4M 1467M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Clovis Oncology CLVS:US $ 392.86M 58.67M
Daiichi Sankyo 4568:JP Y 2294549M 73147M
Eisai 4523:JP Y 1272871M 33556M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
Exelixis EXEL:US $ 2881.4M 227.29M
Genmab GEN:DC DK 27476M 2562M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 8904500M 64400M
Glaxosmithkline GSK:US $ 89045M 644M
Immunogen IMGN:US $ 422.3M 59.41M
Insmed INSM:US $ 1.05B 99.96M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Macrogenics MGNX:US $ 218.04M 53.4M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Moderna Inc MRNA:US 26.04B 1.57B
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Novartis NOVN:VX SF 122910M 2308M
Puma Biotechnology PBYI:US $ 193.65M 7.03M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
Spectrum Pharmaceuticals SPPI:US $ 79.43M 20.62M
Takeda 4502:JP Y 14065426M 887408M
Teva Pharmaceutical TEVA:IT 45.93B 1.13B
Vertex Pharmaceuticals VRTX:US $ 15582.2M 1326.1M
Xencor XNCR:US $ 851.32M 6.6M
YTE INCY:US $ 5319.04M 264.81M